Mantle Cell Lymphoma Biobank

The Mantle cell lymphoma (MCL) biobank opened in 2015, to establish a UK biobank of tumour samples and prospective clinical follow-up on untreated patients with newly diagnosed MCL, in order to develop clinical and biological markers for indolent disease, and establish which patients may undergo a period of watchful waiting before treatment is required. The primary endpoint is defined as time to treatment commencement.

Contact Information

Email:
mclbiobank@plymouth.ac.uk
Telephone:
07971 750959
Address:

Peninsula Clinical Trials Unit
N16, ITTC Building
Plymouth Science Park
 Plymouth
Devon
PL7 8BX
England

Last Updated: 11/09/2021


Annual Statistics

Year Access Requests Received Access Requests Approved
Internal External Commercial Internal External Commercial
2015 N/A N/A N/A N/A N/A N/A
2016 N/A N/A N/A N/A N/A N/A
2017 N/A N/A N/A N/A N/A N/A
2018 N/A N/A N/A N/A N/A N/A
2019 N/A N/A N/A N/A N/A N/A
2020 N/A N/A N/A N/A N/A N/A
2021 N/A N/A N/A N/A N/A N/A
2022 N/A N/A N/A N/A N/A N/A
2023 N/A N/A N/A N/A N/A N/A
2024 N/A N/A N/A N/A N/A N/A
2025 N/A N/A N/A N/A N/A N/A